Lower opioid and higher adjuvant analgesic use in patients on haemodialysis: A single-centre cross-sectional study.

Journal of Clinical Pharmacy and Therapeutics
Onella PereiraMarisa Battistella

Abstract

Opioids are often used to treat chronic non-cancer pain (CNCP) in patients on haemodialysis. Altered pharmacokinetics in this population increases risk for opioid-related adverse events. Although useful in pain management, there is a lack of opioid prescribing guidance for end-stage kidney disease. To characterize opioid usage for CNCP in an outpatient haemodialysis unit. Cross-sectional, single-centre, retrospective cohort study of 272 patients receiving outpatient haemodialysis between 01 June and 31 December 2017. Prevalence of prescription or non-prescription opioids, formulation, indication, dosing, prescriber type and therapeutic effectiveness were evaluated. A total of 27 (10%, aged 58 + 12.1 years, 59% women) patients received opioids for CNCP during the study period. Pain aetiology was diverse; 14 (52%) patients experienced multiple concurrent chronic pain conditions. Hydromorphone (55%) and oxycodone (37%) were the most common prescriptions. A majority (85%) of patients used non-opioid analgesics as adjunct therapy, while half (48%) used benzodiazepines or zopiclone concurrently. Patients who completed a pain scale (n = 10) reported a median pain intensity of 6.8/10 ([IQR], 4.5-7.3). Opioid usage was lower than expect...Continue Reading

References

Nov 17, 1973·British Medical Journal·J K DawbornD J Schiavone
Jun 17, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Steven D WeisbordRobert M Arnold
Dec 5, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Sara N Davison
Oct 27, 2004·Journal of Pain and Symptom Management·Mervyn Dean
Sep 22, 2006·Journal of the American Society of Nephrology : JASN·Ahmad S Barakzoy, Alvin H Moss
Jan 4, 2007·Advances in Chronic Kidney Disease·Fliss E M MurtaghIrene J Higginson
Sep 14, 2007·Kidney International·W C WinkelmayerP S Wang
Dec 22, 2007·Journal of Palliative Medicine·Sara Nicola Davison
Nov 13, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Ahraaz WyneRita S Suri
Oct 23, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Anne M ButlerM Alan Brookhart
Apr 24, 2014·European Journal of Pain : EJP·C S ZinR D Knaggs
Apr 7, 2015·Pain·Rolf-Detlef TreedeShuu-Jiun Wang
Oct 1, 2015·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Robert E OlivoSharmeela Saha
Sep 25, 2017·Journal of the American Society of Nephrology : JASN·Paul L KimmelPaul W Eggers
Jan 4, 2019·MMWR. Morbidity and Mortality Weekly Report·Lawrence SchollGrant Baldwin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.